Recent studies demonstrated the posttranslational alteration of collagens by enzymes like Lysyl oxidases, Focal adhesion kinase, and Prolyl-4-hydroxylases in cancer drug resistance [70,71,72,73,74,75,76,77]. The gene discussed is LOX; the disease is cancer.